Pather S, Charpentier N, van den Ouweland F, Rizzi R, et al. A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine. Vaccine 2024;42:126165.
PMID: 39197299